<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T15:24:13Z</responseDate>
  <request identifier="oai:figshare.com:article/34024042" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34024042</identifier>
        <datestamp>2026-09-29T13:34:49Z</datestamp>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>CO&lt;sub&gt;2&lt;/sub&gt;‑Gated End-Tidal Breathomics
Maps Gastrointestinal Malignant Risk</dc:title>
          <dc:creator>Yuerun Huang (19755436)</dc:creator>
          <dc:creator>Zhiheng Yu (2433805)</dc:creator>
          <dc:creator>Wenshan Wang (12316223)</dc:creator>
          <dc:creator>Yongyan Ji (16504457)</dc:creator>
          <dc:creator>Yichen Zhang (473963)</dc:creator>
          <dc:creator>Shanshan Dong (217931)</dc:creator>
          <dc:creator>Xiang Li (114679)</dc:creator>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>volatile metabolic remodeling</dc:subject>
          <dc:subject>potential mechanistic relevance</dc:subject>
          <dc:subject>multistage risk modeling</dc:subject>
          <dc:subject>including healthy controls</dc:subject>
          <dc:subject>chemical structure enrichment</dc:subject>
          <dc:subject>cell transcriptomic mapping</dc:subject>
          <dc:subject>average waiting time</dc:subject>
          <dc:subject>using breath profiles</dc:subject>
          <dc:subject>derived breath signals</dc:subject>
          <dc:subject>representative voc markers</dc:subject>
          <dc:subject>gastrointestinal malignancy risk</dc:subject>
          <dc:subject>early gastrointestinal abnormalities</dc:subject>
          <dc:subject>associated voc signals</dc:subject>
          <dc:subject>tidal breathomics platform</dc:subject>
          <dc:subject>malignant cases could</dc:subject>
          <dc:subject>tidal breath sampler</dc:subject>
          <dc:subject>quantified 73 vocs</dc:subject>
          <dc:subject>78 – 0</dc:subject>
          <dc:subject>noninvasive disease monitoring</dc:subject>
          <dc:subject>2 &lt;/ sub</dc:subject>
          <dc:subject>breath collection</dc:subject>
          <dc:subject>voc profiling</dc:subject>
          <dc:subject>gastrointestinal diseases</dc:subject>
          <dc:subject>tidal collection</dc:subject>
          <dc:subject>malignant states</dc:subject>
          <dc:subject>diluting disease</dc:subject>
          <dc:subject>noninvasive diagnosis</dc:subject>
          <dc:subject>noninvasive assessment</dc:subject>
          <dc:subject>visualization framework</dc:subject>
          <dc:subject>study establishes</dc:subject>
          <dc:subject>space air</dc:subject>
          <dc:subject>reproducibly identified</dc:subject>
          <dc:subject>reproducible quantification</dc:subject>
          <dc:subject>reflect alterations</dc:subject>
          <dc:subject>readily mixes</dc:subject>
          <dc:subject>partial pressure</dc:subject>
          <dc:subject>oxidative stress</dc:subject>
          <dc:subject>nominated propanal</dc:subject>
          <dc:subject>interpretable visualization</dc:subject>
          <dc:subject>inflammatory responses</dc:subject>
          <dc:subject>gastric cancer</dc:subject>
          <dc:subject>framework revealed</dc:subject>
          <dc:subject>dynamic changes</dc:subject>
          <dc:subject>concept pre</dc:subject>
          <dc:subject>colorectal cancer</dc:subject>
          <dc:subject>cellular metabolism</dc:subject>
          <dc:subject>butyric acid</dc:subject>
          <dc:subject>analytical framework</dc:subject>
          <dc:subject>airway dead</dc:subject>
          <dc:subject>94 ),</dc:subject>
          <dc:description>Human breath volatile organic compounds
(VOCs) reflect
alterations
in cellular metabolism, inflammatory responses and oxidative stress,
providing potential molecular readouts for noninvasive disease monitoring.
However, conventional breath sampling commonly relies on whole-breath
collection, which readily mixes with oral and upper-airway dead-space
air, diluting disease-associated VOC signals that originate from alveolar
exchange and limiting its application in noninvasive diagnosis. To
address this limitation, we developed a CO&lt;sub&gt;2&lt;/sub&gt;-gated intelligent
end-tidal breath sampler (iEBS) based on dynamic changes in end-tidal
CO&lt;sub&gt;2&lt;/sub&gt; partial pressure and coupled it with TD-GC-MS/MS to
establish an end-tidal breathomics platform for VOC profiling. Using
breath profiles from 273 participants, including healthy controls
and individuals with gastritis, polyps, gastric cancer and colorectal
cancer, we reproducibly identified and quantified 73 VOCs. By integrating
topological data analysis, multistage risk modeling, chemical structure
enrichment and single-cell transcriptomic mapping, we constructed
a visualization framework for gastrointestinal malignancy risk. This
framework revealed a gradient of volatile metabolic remodeling from
early gastrointestinal abnormalities to malignant states and nominated
propanal, butyric acid and 1-butanol as representative VOC markers
with potential mechanistic relevance. The multistage risk model achieved
stable disease stratification performance (AUC = 0.78–0.94),
and a proof-of-concept pre-endoscopic triage simulation estimated
that the average waiting time for malignant cases could be reduced
by 20%. Overall, this study establishes an iEBS-based breath VOC profiling
approach for phase-controlled end-tidal collection, reproducible quantification
and interpretable visualization of alveolar-derived breath signals,
providing an analytical framework for the noninvasive assessment of
gastrointestinal diseases.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.analchem.6c04424.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/CO_sub_2_sub_Gated_End-Tidal_Breathomics_Maps_Gastrointestinal_Malignant_Risk/34024042</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
